Correlation between annual change in health status and computer tomography derived lung density in subjects with α1-antitrypsin deficiency

Background: There is increasing recognition that questionnaires of health status and lung density measurements are more sensitive tools for assessing progression of emphysema than forced expiratory volume in 1 second (FEV1) and transfer coefficient (Kco). A study was undertaken to investigate prospectively the correlation between annual change in health status and computer tomography (CT) derived lung density in subjects with α1-antitrypsin deficiency. Methods: Twenty two patients of mean (SD) age 40.7 (9.2) years with ZZ type α1-antitrypsin deficiency were investigated at baseline and 30 months later by FEV1 and Kco, St George Respiratory Questionnaire (SGRQ), and by a spiral CT scan of the chest. CT data of chest images were analysed using software designed for automated lung contour detection and lung density measurements. The density data were corrected for changes in inspiration levels. Results: Changes in lung density, expressed as 15th percentile point or relative area below –950 HU, correlated well with changes in health status (SGRQ total score): R = −0.56, p = 0.007 or R = 0.6, p  = 0.003. Neither changes in health status nor changes in lung density correlated significantly with changes in FEV1 or changes in Kco. Conclusions: The SGRQ total score (which is a global measure in COPD) and lung density (a specific measure of emphysema) are sensitive to deterioration in patients with α1-antitrypsin deficiency. This finding may facilitate future studies with new drugs specific for emphysema, a frequently occurring component of COPD.

[1]  S. Spencer,et al.  Bronchodilator reversibility testing in chronic obstructive pulmonary disease , 2003, Thorax.

[2]  S. Spencer,et al.  Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study , 2003, Thorax.

[3]  P M Calverley,et al.  Health status deterioration in patients with chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[4]  J. Roca,et al.  Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[5]  I. Pavord,et al.  Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial , 2000, The Lancet.

[6]  R. Stockley,et al.  Alpha-1-antitrypsin deficiency: what next? , 2000, Thorax.

[7]  W. B. Hunt,et al.  Pulmonary emphysema and alpha-1 antitrypsin deficiency. , 1972, Virginia medical monthly.

[8]  F. Gleeson,et al.  BTS guidelines for the management of pleural infection , 2003, Thorax.

[9]  A. Miller,et al.  Standardized lung function testing. , 1984, Bulletin europeen de physiopathologie respiratoire.

[10]  M Thomas,et al.  Breathing exercises and asthma , 2003, Thorax.

[11]  H A Vrooman,et al.  Sources of error in lung densitometry with CT. , 1999, Investigative radiology.

[12]  J. C. Caminero Luna [Pleural tuberculosis]. , 1990, Medicina clinica.

[13]  J E Earis,et al.  The inspiratory "squawk" in extrinsic allergic alveolitis and other pulmonary fibroses. , 1982, Thorax.

[14]  A. Vyshedskiy,et al.  Sound transmission in the lung as a function of lung volume. , 2002, Journal of applied physiology.

[15]  R. Stockley,et al.  Longitudinal changes in physiological, radiological, and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with decline. , 2001, American journal of respiratory and critical care medicine.

[16]  P De Vuyst,et al.  Comparison of computed density and macroscopic morphometry in pulmonary emphysema. , 1995, American journal of respiratory and critical care medicine.

[17]  J. Best,et al.  CT measurements of lung density in life can quantitate distal airspace enlargement--an essential defining feature of human emphysema. , 1988, The American review of respiratory disease.

[18]  J. Roca,et al.  Standardization of the measurement of transfer factor (diffusing capacity) , 1993, European Respiratory Journal.

[19]  M. Jacobs,et al.  Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin , 1994, Antimicrobial Agents and Chemotherapy.

[20]  A. Tattersfield,et al.  Effect of two breathing exercises (Buteyko and pranayama) in asthma: a randomised controlled trial , 2003, Thorax.

[21]  P. Jones,et al.  Quality of life changes in COPD patients treated with salmeterol. , 1997, American journal of respiratory and critical care medicine.

[22]  P. Jones Interpreting thresholds for a clinically significant change in health status in asthma and COPD , 2002, European Respiratory Journal.

[23]  S. Spencer,et al.  Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial , 2000, BMJ : British Medical Journal.

[24]  P. Jones,et al.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.

[25]  P. Jones,et al.  The St George's Respiratory Questionnaire. , 1991, Respiratory medicine.

[26]  W. F. Miller,et al.  Pulmonary emphysema and alpha 1-antitrypsin deficiency. , 1968, The American journal of medicine.

[27]  E. Piitulainen,et al.  Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ). , 1999, The European respiratory journal.

[28]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.

[29]  H A Vrooman,et al.  A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. , 1999, American journal of respiratory and critical care medicine.

[30]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[31]  P. D. Oldham,et al.  A note on the analysis of repeated measurements of the same subjects. , 1962, Journal of chronic diseases.

[32]  E. Ernst Complementary therapies for asthma: what patients use. , 1998, The Journal of asthma : official journal of the Association for the Care of Asthma.

[33]  M. Pearson Guidelines for the management of chronic obstructive pulmonary disease. , 1999, Caribbean health.

[34]  S. Eriksson,et al.  PULMONARY EMPHYSEMA AND ALPHA1-ANTITRYPSIN DEFICIENCY. , 2009, Acta medica Scandinavica.

[35]  M. Partridge,et al.  The use of complementary medicines by those with asthma. , 2003, Respiratory medicine.

[36]  I. Pavord,et al.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.